The global epinephrine market growth was impacted negatively during the forecast period. Moreover, favorable reimbursement policies for auto-injectors, increasing launches of technologically advanced products, and growing prevalence of various diseases, such as anaphylaxis, cardiovascular diseases, and others will support the market growth of epinephrine during the forecast period.ĭelayed Diagnosis of New Cases during COVID-19 Marginally Impacted the Market Owing to the therapeutic effect, the demand for various technologically advanced products is increasing, which includes auto-injectors and others. It is administered in various ways, such as intramuscular, subcutaneous, intravenous, and inhalation. The most common factors responsible for anaphylaxis are food, insect stings, medications, and allergy immunotherapy injections. Based on our analysis, the global market exhibited a lower growth of 11.4% in 2020 as compared to 2019.Įpinephrine is one of the most commonly used medications and hormones for treatment in various situations, including emergency treatment of type 1 hypersensitivity reactions such as anaphylaxis. The global COVID-19 pandemic has been unprecedented and staggering, with epinephrine experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The market is projected to grow from USD 1.75 billion in 2022 to USD 3.63 billion by 2029, exhibiting a CAGR of 11.0% during the forecast period.
The global epinephrine market size was valued at USD 1.60 billion in 2021.
0 kommentar(er)
